Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland

Epidemiology and Infection

Volumn 119, Issue 1, 1997, Pages 29-34

  Kosunen, T U ^a   Aromaa, A ^b,c   Knekt, P ^b,c   Salomaa, A ^d   Rautelin, H ^a   Lohi, P ^a   Heinonen, O P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d Vammala Health Center   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; FINLAND; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBODIES, BACTERIAL; FEMALE; FINLAND; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS;

EID: 0030757545     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268897007565     Document Type: Article

References (26)

1. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfil Koch's postulates for pyloric campylobacter. Med J Aust 1985; 142: 436-9.
2. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161: 626-33.
3. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
4. Nomura A, Stemmermann GN, Chyou P-H, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 321: 1132-6.
5. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302: 1302-5.
6. Aromaa A, Kosunen TU, Knekt P, et al. Circulating anti-Helicobacter pylori IgA antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 1996; 144: 142-9.
7. Jones DM, Eldridge J, Fox AJ, Sethi P, Whorwell PJ. Antibody to the gastric campylobacter-like organism ('Campylobacter pyloridis') - clinical correlations and distribution in the normal population. J Med Microbiol 1986; 22: 57-62.
8. Valle J, Seppälä K, Sipponen P, Kosunen TU. Disappearance of gastritis after eradication of Helicobacter pylori: a morphometric study. Scand J Gastroenterol 1991; 26: 1057-66.
9. Kosunen TU, Seppälä K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992; 339: 893-5.
10. Strauss RM, Wang TC, Kelsey PB, et al. Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med 1990; 89: 464-9.
11. Seppälä K, Sipponen P, Kosunen TU. Do changes in gastritis and serum antibodies reflect successful triple therapy in Helicobacter pylori infection? Gastroenterology 1993; 104: Suppl. A189.
12. Talley NJ, Noack KB. The worldwide prevalence of Helicobacter pylori : asymptomatic infection and clinical states associated with infection in adults. In: Goodwin CS, Worsley BW, eds. Helicobacter pylori: Biology and clinical practice. Boca Raton, Florida : CRC Press, Inc., 1993: 63-83.
13. Kosunen TU, Höök J, Rautelin HI, Myllylä G. Age dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol 1989; 24: 110-4.
14. Parsonnet J, Blaser MJ, Perez-Perez GI, Hargrett-Bean N, Tauxe RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992; 102: 41-6.
15. Kuipers EJ, Peña AS, van Kamp G, et al. Seroconversion for Helicobacter pylori. Lancet 1993; 342: 328-31.
16. Banatvala N, Mayo K, Mégraud F, Jennings R, Decks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: 219-21.
17. Sipponen P, Kosunen TU, Samloff IM, Heinonen OP, Siurala M. Rate of Helicobacter pylori aquisition among Finnish adults. A 15-year follow-up. Scand J Gastroenterol 1996; 31: 229-32.
18. Veldhuyzen van Zanten SJ, Pollak PT, Best LM, Bezanson GS, Marrie T. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis 1994; 169: 434-7.
19. Statistical yearbook of Finland 1974. Helsinki: Central Statistical Office of Finland, 1975.
20. Statistical yearbook of Finland 1994. Helsinki: Central Statistical Office of Finland, 1995.
21. Searle SR. Linear models. New York: Wiley, 1971.
22. Bamford KB, Bickley J, Collins JSA, et al. Helicobacter pylori: comparison of DNA fingerprints provides evidence for intrafamiliar infection. Gut 1993; 34: 1348-50.
23. Pukkala E, Gustavsson N, Teppo L, eds. Atlas of cancer incidence in Finland 1953-1982. (CSF publication No. 37). Helsinki: Cancer Society of Finland, 1987: 20.
24. Finnish Cancer Institute Registry - Institute for Statistical and Epidemiological Cancer Research. Cancer incidence in Finland 1993. (CSF publication No. 56). Helsinki: Cancer Society of Finland, 1995: 16-9.
25. Glise H. Epidemiology in peptic ulcer disease. Current status and future aspects. Scand J Gastroenterol 1990; Suppl 175: 13-8.
26. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer : epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8: 1-27.